Industry Special Interest Group (I-SIG)
[Formerly the Industry Advisory Committee (IAC)]
Who is the I-SIG?
The Industry Special Interest Group (I-SIG) members are a diverse group of researchers from the pharmaceutical and device industry, academia and consulting, who share a common interest in the application of patient-centered outcomes, including health-related quality of life (HRQOL), in research important to industry.
We are interested in innovative methods and research in patient-centered outcomes measurement for use in research important to industry.
What are our aims?
The purpose of the I-SIG is to synthesize, share, promote and educate on industry-related patient-centered outcomes research by bringing individuals together who are interested in topics of joint interest to industry and ISOQOL.
Our specific goals are to:
- Learn, develop and promote best practice in the field of patient-centered outcomes research and implementation in industry-related research
- Provide support to I-SIG members and stimulate research in this field
- Encourage I-SIG members to meet and share relevant research and experiences through ISOQOL and at other professional meetings
- Increase awareness among the general ISOQOL members of issues important to industry
Our research includes, among others topics:
- Methods for selecting, developing or adapting patient-centered outcomes instruments for use in industry-related research
- Testing the feasibility and usability of patient-centered outcomes instruments
- Implementation of patient-centered outcomes instruments in industry-related research
- Design of studies involving patient-centered outcomes instruments
- Analysis and interpretation of patient-centered outcomes data
- See links below to our online education webinars related to these research topics
Current I-SIG Initiatives:
2018 Annual Report
Annual Conference Activities:
2019 Annual Symposium: topic to be determined
Past Symposium Topics:
- 2018: Meaning in movement: Defining valid endpoints using data collected with mobile technology tools
- 2017: Real-world evidence to support approval and reimbursement: new frontier?
- 2016: Incorporating the patient voice in benefit risk assessment and regulatory/HTA decision making
- 2015: Bring Your Own Device (BYOD): trends, best practices, challenges….where do PRO measures go from here?
- 2014: Advancing Measurement Science Beyond PROs: Patient-Centeredness and Validity Across All Clinical Outcome Assessments
- 2013: Innovations for Patient Engagement in Health Outcomes Development, Selection and Measurement: Opportunities and Limitations
- 2012: Perspectives on Mixed Methods to Assess Content Validity of a Patient Reported Outcome
- 2011: To Qualify or Not to Qualify: Benefits and Challenges of PRO Instrument Qualification from Industry, Academic, and Regulatory Perspectives
Communication and Information Sharing
We encourage active communication between members.
- Connect with other I-SIG researchers using the ISOQOL Membership Directory.
- Review the Quality of Life Quarterly, ISOQOL's quarterly newsletter, to keep up to date.
- Consider the I-SIG Teamwork and ISOQOL LinkedIn as a way to connect with fellow I-SIG members.
- Contact one of the I-SIG leaders listed below for more information.
- Visit the Education page for announcements of upcoming webinars.
- View archived webinars available on ISOQOL website:
Co-Chair: Paivi Miskala, MSPH, PhD
Co-Chair: Linda Nelsen, MHS
Josephine Norquist, MS